December 2018 reports are now online. These documents are available to our stakeholders only (username and password required). Access is via the 'Financial Headlines' link in the Prescribing Analysis Reports section of this site.
Published: Thu, 21 Feb 2019 12:10:42 +0000
Our February 2019 Monthly Horizon Scanning Report is now available.
Please see our Monthly Horizon Scanning Reports page.
Published: Wed, 13 Feb 2019 10:23:35 +0000
An update to our Pain management report with 2018/2019 Q2 data are now available online. This is available to our stakeholders only (username and password required). Access is via the Prescribing Analysis Reports section of this site (Under the Prescribing Analysis Reports menu, click on the 'Therapeutic' menu item followed by the ‘Central Nervous System’ heading).
Published: Mon, 11 Feb 2019 12:50:11 +0000
Updates to our bone metabolism and genito-urinary reports with 2018/2019 Q2 data are now available online. These are available to our stakeholders only (username and password required). Access is via the Prescribing Analysis Reports section of this site (Under the Prescribing Analysis Reports menu, click on the 'Therapeutic' menu item followed by the relevant BNF heading)
Published: Thu, 07 Feb 2019 12:42:33 +0000
Published: Thu, 31 Jan 2019 16:16:10 +0000
Published: Fri, 25 Jan 2019 14:29:21 +0000
Our Cost Comparison Charts and Switch Saving Calculators have been updated for January 2019. The latest Excel, Word and PDF versions of the Cost Comparison Charts are available to our stakeholders only (user and password required). The charts are located here.
The Switch Saving Calculators are also available to stakeholders only. Access is via the Prescribing Analysis Reports menu, under the Cost Impact and Savings submenu item.
Published: Fri, 25 Jan 2019 14:08:22 +0000
November 2018 reports are now online. These documents are available to our stakeholders only (username and password required). Access is via the 'Financial Headlines' link in the Prescribing Analysis Reports section of this site.
Published: Thu, 24 Jan 2019 13:39:12 +0000
Antimicrobial drugs report for April 2018 to Sep 2018 is now avialable. This document is available to our stakeholders only (username and password required). Access is via the Prescribing Analysis Reports section of this site (Under the Prescribing Analysis Reports menu, click on the Therapeutic menu item and then on Antimicrobial).
Published: Thu, 24 Jan 2019 12:18:10 +0000
The new evaluation report on the use ActiPatch for the management of localised musculoskeletal pain is now online. This review aims to give objective information and guidance on efficacy, adverse effects, place in treatment and arrangements for prescribing to commissioners of health services, prescribers and others.
Published: Thu, 17 Jan 2019 15:11:21 +0000
Sorry. This post is restricted. Please log-in @ https://medicines.necsu.nhs.uk/medicines-optimisation-sign-in to view.
The post Supply Issues in Primary Care – Update January 2019 appeared first on NECS Medicines Optimisation.Prescribing Newsletter Supply Issues_Shortages
Published: Thu, 07 Feb 2019 11:45:23 +0000
The Chief Pharmaceutical Officer for England has written to pharmacists working in and with the NHS in England to update them on Government contingency plans for continuity of medicines supply in the event of a No Deal Exit from the EU. The letter reiterates advice about the additional pressure on medicines supplies that stockpiling can cause and provides information Continue Reading »
The post Medicines Supply Continuity – Update on No Deal EU Exit Contingency Plans appeared first on NECS Medicines Optimisation.Memos and Alerts News Prescribing Newsletter Supply Issues_Shortages
Published: Tue, 22 Jan 2019 17:55:02 +0000
The Department of Health & Social Care have published a policy paper on access to medicines in the UK – including information about contingency plans for a ‘No Deal Brexit’. DHSC 18/01/2019 The government is working with pharmaceutical companies, suppliers, and the NHS to make sure patients continue to receive the medication they need if the UK leaves Continue Reading »Memos and Alerts News Prescribing Newsletter Supply Issues_Shortages
Published: Tue, 22 Jan 2019 17:27:31 +0000
UKMi publish a series of Q&A documents on the NHS SPS website, with summaries of high quality, evidence-based, and quality controlled answers to common or unusual Medicines Information enquiries. The latest batch of seven new or updated Q&As was published in December: Which medicines require extra care when switching between liquid and tablet/capsule formulations? Information on medicines which require Continue Reading »Memos and Alerts News Prescribing Newsletter
Published: Mon, 21 Jan 2019 15:38:26 +0000
The UK Medicines Infomation network publish a series of Question & Answer documents via the NHS Specialist Pharmacy Service website. The Q&As are a response to demand for accessible summaries of high quality, evidence-based, and quality controlled answers to common or unusual enquiries made to Medicines Information services. A full list of current UKMi Q&As can be found here, Continue Reading »Memos and Alerts
Published: Mon, 21 Jan 2019 15:15:23 +0000
Carbimazole is associated with an increased risk of congenital malformations, especially when administered in the first trimester of pregnancy and at high doses.
If acute pancreatitis occurs during treatment with carbimazole, immediately and permanently stop treatment.
If Fournier’s gangrene is suspected, stop the SGLT2 inhibitor and start treatment urgently (including antibiotics and surgical debridement).
Letters were sent to healthcare professionals about Lartruvo▼ (olaratumab), quadrivalent influenza vaccine (split virion, inactivated), SGLT2 inhibitors, and carbimazole and thiamazole (synonym: methimazole)-containing products. Class 2 medicines recalls were issued for batches of irbesartan/hydrochlorothiazide and irbesartan tablets.
Alerts were issued about FreeStyle Libre flash glucose sensors and Arjo Minstrel passive floor lifts (portable hoist).
Healthcare professionals should not prescribe them to newly diagnosed patients as first-line treatment, except for those with severe hypertriglyceridaemia or those who cannot take statins.
Tapentadol may increase seizure risk in patients taking other medicines that lower seizure threshold, for example, antidepressants and antipsychotics.
Patients on ipilimumab who present with diarrhoea or other symptoms of colitis, and those who do not respond to steroid treatment for immune-related colitis, should be investigated to exclude other causes, including infections such as cytomegalovirus (CMV).
The Yellow Card App has been updated to make it easier to use, to have useful new features, and to support reporting a suspected reaction related to medicine exposure during pregnancy.
In December 2018, a letter was sent to notify healthcare professionals of the discontinuation of Zovirax (Aciclovir) eye ointment.
Northern Treatment Advisory Group: http://ntag.nhs.uk/html/latest_news.html